Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What dose contraints do use for the pulmonary artery and vein when treating with a lung lesion with SBRT?
Related Questions
Do you use an LAD constraint in the setting of BID thoracic radiation for SCLC?
How well does a negative non-contrast MRI of the brain exclude metastasis in a patient with squamous cell carcinoma of the lung?
For NSCLC patients treated with neoadjuvant chemoimmunotherapy and surgery with ypN2 disease, what factors would cause you to recommend PORT?
What is the role of consolidative durvalumab and prophylactic cranial irradiation in patients with stage I small cell lung cancer?
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
What are your top takeaways in Thoracic Cancers from ASTRO 2024?
Would presence of an SVC stent affect your decision to offer BID vs once-daily chemoradiation for SCLC?
Would you give durvalumab consolidation to a patient with stage III NSCLC with an STK11 mutation?
In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?
Would you give lung SBRT to a patient with bullous pemphigoid on the chest and torso?
